Antimicrobial and Diagnostic Stewardship Program
Northwestern Medicine is committed to improving antibiotic use to ensure that antibiotics remain effective treatment options.
Our mission is to advocate for optimal antimicrobial use and diagnostic testing for every patient to improve clinical outcomes, prevent drug resistance, enhance quality and safety, and advance research. Our vision is to achieve a widespread culture of antimicrobial stewardship across our health system and communities where antimicrobials are protected for future generations. Our goals for 2024 are to advance stewardship efforts to optimize outcomes and antibiotic use to provide a consistent level of care across all of Northwestern Medicine. |
News and Events
|
This website is primarily intended to be used as a resource for NM clinicians. Guidance is designed to improve and standardize the quality of patient care, but it should not be used without clinical judgement.
Recent Updates
UTI and Asymptomatic Bacteriuria Guidance
Sept 2024 | System-wide Beta-Lactam Allergy Risk Assessment and Cross-Reactivity Chart Sept 2024 | System-wide |
COVID-19 Treatment Guideline
Oct 2024 | System-wide Skin and Soft Tissue Infection (SSTI) Clinical Pathway & Treatment Guidance May 2024 | System-wide |
Renal Dosing Guidance
Jun 2024 | System-wide Biofire® FilmArray® Blood Culture Identification Panel Clinician Guidance Mar 2024 | System-wide |
rESOURCES
Why Our Work Matters
The Northwestern Medicine Antimicrobial Stewardship Team works continuously to support our clinicians in their decision to prescribe antibiotic orders. Please reach out to your hospital's antibiotic stewardship team for resources and clinical decision support.
|